Ascendis Pharma A/S
ASND
$158.19
-$3.34-2.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 559.80M | 579.30M | 697.65M | 277.18M | 345.49M |
| Total Receivables | 83.03M | 183.70M | 56.16M | 86.45M | 74.11M |
| Inventory | 316.77M | 306.05M | 296.04M | 269.15M | 251.03M |
| Prepaid Expenses | 36.39M | 29.27M | 36.18M | 39.37M | 45.85M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 995.99M | 1.10B | 1.09B | 672.15M | 716.49M |
|
|
|||||
| Total Current Assets | 995.99M | 1.10B | 1.09B | 672.15M | 716.49M |
| Net Property, Plant & Equipment | 99.92M | 102.20M | 108.77M | 111.48M | 115.62M |
| Long-term Investments | -- | 3.62M | -- | -- | -- |
| Goodwill | -- | 3.62M | -- | -- | -- |
| Total Other Intangibles | 4.23M | 551.80K | 4.58M | 4.49M | 4.64M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.87M | 2.40M | 2.46M | 2.34M | 2.30M |
| Total Assets | 1.15B | 1.22B | 1.22B | 812.49M | 865.79M |
|
|
|||||
| Total Accounts Payable | 91.19M | 99.80M | 83.95M | 106.64M | 101.98M |
| Total Accrued Expenses | 41.14M | 70.36M | 47.11M | 28.30M | 24.49M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 529.57M | 508.89M | 501.60M | 486.00M | 474.04M |
| Total Finance Division Other Current Liabilities | 295.20M | 260.87M | 302.49M | 287.38M | 261.47M |
| Total Other Current Liabilities | 295.20M | 260.87M | 302.49M | 287.38M | 261.47M |
| Total Current Liabilities | 957.10M | 939.91M | 935.15M | 908.32M | 861.98M |
|
|
|||||
| Total Current Liabilities | 957.10M | 939.91M | 935.15M | 908.32M | 861.98M |
| Long-Term Debt | 300.56M | 297.68M | 293.94M | 147.81M | 158.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 85.64M | 80.29M | 84.07M | 86.90M | 89.74M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 9.11M | 12.69M | 15.30M | 13.55M | 13.04M |
| Total Liabilities | 1.35B | 1.33B | 1.33B | 1.16B | 1.12B |
|
|
|||||
| Common Stock & APIC | 2.67B | 2.54B | 2.73B | 2.31B | 2.32B |
| Retained Earnings | -2.87B | -2.65B | -2.84B | -2.65B | -2.58B |
| Treasury Stock & Other | 1.76M | 1.73M | 931.30K | 729.70K | 718.50K |
| Total Common Equity | -205.15M | -109.44M | -108.54M | -344.08M | -256.96M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -205.15M | -109.44M | -108.54M | -344.08M | -256.96M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -205.15M | -109.44M | -108.54M | -344.08M | -256.96M |
|
|
|||||